Growth Curve Bio
Durham, US · Founded 2023 · Delaware LLC
Growth Curve Bio operates an R&D-grade precision fermentation facility specializing in microbial fermentation for synthetic biology programs, serving biotech and life sciences companies developing novel products. The company provides integrated services from strain optimization through pilot-scale manufacturing, combining contract research with GMP-informed documentation and process validation to de-risk commercialization.
Founders & leadership
Growth Curve Bio was founded in 2023 by Hunter.
H
HunterCo-founder
BS
Ben SchultzCo-founder
ES
Eric SaboFounder & Leader
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2024
▶$3.5MraisedJul 2024 · 1 investors · BiotechnologyRule 506(b)
▶$3.5MraisedJul 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ben SchultzExecutive Officer, Director
- Eric SaboExecutive Officer, Director, Promoter
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Jun 2024
- Incorporated
- Limited Liability Company, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Growth Curve Bio do?
- Growth Curve Bio operates an R&D-grade precision fermentation facility specializing in microbial fermentation for synthetic biology programs, serving biotech and life sciences companies developing novel products. The company provides integrated services from strain optimization through pilot-scale manufacturing, combining contract research with GMP-informed documentation and process validation to de-risk commercialization.
- Who founded Growth Curve Bio?
- Growth Curve Bio was founded by Hunter in 2023.
- How much funding has Growth Curve Bio raised?
- Growth Curve Bio has disclosed $3.5M raised across 1 round.
- Where is Growth Curve Bio headquartered?
- Growth Curve Bio is headquartered in Durham, US.